Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHarvey Nash Group Regulatory News (HVN)

  • There is currently no data for HVN

Form 8.5 (EPT/RI) - Harvey Nash Group PLC

10 Oct 2018 08:59

RNS Number : 5718D
Panmure Gordon & Co. plc
10 October 2018
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Panmure Gordon (UK) Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Harvey Nash Group PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

Harvey Nash Group PLC

(d) Date dealing undertaken:

09 October 2018

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

5p Ordinary

Purchase

 

3,000

130.5p

 

130.5p

 

5p Ordinary

Sales

15,378

130p

126.5p

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

Date of disclosure:

10 October 2018

Contact name:

Nick Entwisle

Telephone number:

020 7886 2850

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FERURVBRWWARARA
Date   Source Headline
1st Aug 20174:32 pmRNSDirector/PDMR Shareholding
1st Aug 20177:00 amRNSTotal Voting Rights
28th Jul 20178:16 amRNSAdmission to AIM
28th Jul 20178:00 amRNSCancellation Harvey Nash Group PLC
3rd Jul 20172:24 pmRNSAcquisition of PAT Management AB
3rd Jul 20177:00 amRNSTotal Voting Rights
30th Jun 20174:23 pmRNSDirector/PDMR Shareholding
29th Jun 20172:00 pmRNSSchedule 1 - Harvey Nash Group Plc
29th Jun 201712:49 pmRNSMove to AIM - Results of General Meeting
29th Jun 201712:49 pmRNSResults of Annual General Meeting
29th Jun 20177:00 amRNSAGM Statement
12th Jun 20177:00 amRNSBlock listing Interim Review
5th Jun 201712:35 pmRNSMove to AIM and notice of GM
2nd Jun 20175:26 pmRNSDirector/PDMR Shareholding
1st Jun 20177:00 amRNSTotal Voting Rights
31st May 20179:06 amRNSHolding(s) in Company
26th May 20174:57 pmRNSHolding(s) in Company
10th May 20175:07 pmRNSHolding(s) in Company
9th May 20174:00 pmRNSHolding(s) in Company
3rd May 20173:40 pmRNSHolding(s) in Company
3rd May 201711:30 amRNSDirector/PDMR Shareholding
2nd May 20177:00 amRNSTotal Voting Rights
28th Apr 20179:35 amRNSHolding(s) in Company
27th Apr 20177:00 amRNSDirectorate Change
27th Apr 20177:00 amRNSFinal Results
3rd Apr 201710:51 amRNSDirector/PDMR Shareholding
3rd Apr 20177:00 amRNSTotal Voting Rights
28th Mar 20175:01 pmRNSHolding(s) in Company
9th Mar 20177:00 amRNSAppointment of Group Finance Director
7th Mar 20175:04 pmRNSHolding(s) in Company
6th Mar 20175:21 pmRNSHolding(s) in Company
3rd Mar 20175:15 pmRNSDirector/PDMR Shareholding
3rd Mar 20177:00 amRNSPre-close Trading Update and Notice of Results
1st Mar 20177:00 amRNSTotal Voting Rights
3rd Feb 201711:54 amRNSDirector/PDMR Shareholding
1st Feb 20177:00 amRNSTotal Voting Rights
26th Jan 20175:50 pmRNSHolding(s) in Company
4th Jan 20173:55 pmRNSDirector/PDMR Shareholding
3rd Jan 20177:00 amRNSTotal Voting Rights
12th Dec 20167:00 amRNSBlock listing Interim Review
1st Dec 20167:00 amRNSTotal Voting Rights
30th Nov 20162:37 pmRNSDirector/PDMR Shareholding
1st Nov 20167:00 amRNSChange of Adviser
1st Nov 20167:00 amRNSTotal Voting Rights
27th Oct 20165:10 pmRNSDirector/PDMR Shareholding
3rd Oct 20167:00 amRNSTotal Voting Rights
30th Sep 20165:19 pmRNSDirector/PDMR Shareholding
29th Sep 20167:00 amRNSUnaudited Half-year Results
5th Sep 20167:00 amRNSNotice of Results
1st Sep 20164:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.